Insider Trading May 19, 2026 09:18 PM

MeiraGTx CEO Sells Shares Amid Biotech Progress and Strategic Funding

Analysis of insider transactions and recent corporate developments for MeiraGTx Holdings plc (NASDAQ:MGTX)

By Jordan Park MGTX

The President & CEO of MeiraGTx Holdings plc, Forbes Alexandria, recently sold a significant block of company shares. This transaction occurred amidst several positive developments for the firm, including a strategic collaboration with Hologen Limited and plans for a large public offering to fund future operations. Financial analysts have also been increasing price targets following positive data from key drug programs.

MeiraGTx CEO Sells Shares Amid Biotech Progress and Strategic Funding
MGTX

Key Points

  • Strategic Partnerships and Development:
  • MeiraGTx announced the completion of a strategic collaboration with Hologen Limited. This partnership is focused on advancing investigational gene therapies for specific conditions, including Parkinson’s disease and various genetic obesity disorders.
  • Financial Capitalization:
  • The company has also priced an underwritten public offering. The goal of this offering is to raise approximately $100 million in capital. These funds are intended to support ongoing operations and potential commercial launches through the year 2028.

The recent filing of an insider sale by MeiraGTx Holdings plc (NASDAQ:MGTX) President & CEO, Forbes Alexandria, signals activity in the company's share structure. According to a Form 4 submission filed with the Securities and Exchange Commission, Ms. Forbes sold 62,000 ordinary shares of MeiraGTx stock on May 19, 2026. The total value realized from these transactions amounted to $568,540.

The sale was structured across multiple trades, with the per-share prices ranging between $8.96 and $9.32. This resulted in a weighted average sale price of $9.17 per share. Notably, these shares were liquidated under the framework of a Rule 10b5-1 trading plan, a mechanism Ms. Forbes adopted on November 18, 2025.

This insider selling activity takes place against a backdrop of substantial performance and corporate milestones for MeiraGTx. Over the past year, the company's stock has achieved a 66% return, currently trading at $9.13. Despite this appreciation, InvestingPro analysis suggests that the stock may be slightly overvalued compared to its Fair Value estimate. While analysts have set price targets spanning from $19 to $50, the company currently maintains a

Risks

  • Valuation Concerns:
  • InvestingPro analysis indicates that, despite recent stock appreciation, MeiraGTx appears slightly overvalued when measured against its Fair Value estimate.
  • Profitability Outlook Uncertainty (Sector Impact: Biotech/Pharmaceuticals): The InvestingPro Tips suggest that profitability challenges persist. Furthermore, analysts are not currently anticipating any profits for the company this year.

More from Insider Trading

Silver Lake Affiliate Executes $142K Dell Sale Near 52-Week High Jun 4, 2026 GoDaddy's Chief Accounting Officer Divests Shares Amidst Broader Market Headwinds Jun 4, 2026 GoDaddy CFO Mark McCaffrey Sells $355,665 in GDDY Stock Jun 4, 2026 Silver Lake Entities Liquidate $8.2 Million in Dell Technologies Shares Amid Strong Stock Performance Jun 4, 2026 Silver Lake Affiliates Liquidate $32.6 Million in Dell Technologies Shares Amid Strong Analyst Optimism Jun 4, 2026